Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, Non-Hodgkin × lucatumumab × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 53 Rituximab 47 fludarabine 30 fludarabine phosphate 29 venetoclax 23 Filgrastim 21 Etoposide 18 Bendamustine Hydrochloride 15 Melphalan 14 Peripheral Blood Stem Cell Transplantation 13 Gemcitabine 13 obinutuzumab 12 Lenalidomide 11 Cytarabine 11 Bortezomib 11 Vorinostat 10 Dexamethasone 10 Azacitidine 10 Vincristine 9 Tacrolimus 9 Whole-Body Irradiation 8 Prednisone 8 Mycophenolic Acid 8 Doxorubicin 8 Carmustine 8 pembrolizumab 7 ibrutinib 7 copanlisib 7 aldesleukin 7 Specimen Handling 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01275209 2020-12-08

LIFT

Novartis

Phase 1 Completed

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡